HI
QTTB icon

Harbour Investments’s Q32 Bio QTTB Stock Holding History

Harbour Investments’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$71 Hold
11
– – ﹤0.01% 4546
2025
Q4 		$37 Hold
11
– – ﹤0.01% 3801
2025
Q3 		$22 Hold
11
– – ﹤0.01% 3709
2025
Q2 		$16 Hold
11
– – ﹤0.01% 3579
2025
Q1 		$18 Hold
11
– – ﹤0.01% 3525
2024
Q4 		$38 Hold
11
– – ﹤0.01% 3446
2024
Q3 		$491 Hold
11
– – ﹤0.01% 3202
2024
Q2 		$197 Buy
+11
New +$263 ﹤0.01% 3163
2021
Q4 		– Sell
-5
Closed -$1K – 3760
2021
Q3 		$1K Hold
5
– – ﹤0.01% 3627
2021
Q2 		$1K Hold
5
– – ﹤0.01% 3673
2021
Q1 		$1K Buy
+5
New +$1.05K ﹤0.01% 3514

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Harbour Investments's QTTB Position: Q1 2026 in Review

Harbour Investments held its Q32 Bio (QTTB) position steady in Q1 2026 at 11 shares worth $71. The position accounts for ﹤0.01% of the portfolio, ranked #4546.

Harbour Investments first reported a position in QTTB in Q1 2021 and has held it in 11 quarters since. The position peaked at $1K in Q3 2021. 54 funds tracked by Wall St. Rank hold QTTB as of Q1 2026.

  • Harbour Investments held 11 shares of Q32 Bio worth $71 as of Q1 2026.
  • Harbour Investments left its Q32 Bio share count unchanged in Q1 2026.
  • Q32 Bio made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #4546 holding.
  • Harbour Investments first reported a position in Q32 Bio in Q1 2021 and has held it in 11 quarters since.
  • Harbour Investments's Q32 Bio position peaked at $1K in Q3 2021.
  • 54 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.